BIOANALYTICAL TESTING SERVICES MARKET ANALYSIS

Key Developments

• In November 2023, Resolian uccessfully completed the acquisition of Denali Medpharma, a prominent bioanalytical contract research organization (CRO) based in China. This acquisition enabled Resolian to broaden its bioanalysis laboratory operations, spanning facilities in the U.S., UK, Australia, and China.
• In September 2023, Cerba HealthCare, clinical pathology laboratory finalized the acquisition of CIRION BioPharma Research, a Canada-based contract research laboratory, to bolster its bioanalytical capabilities and streamline the implementation of complex clinical trials
• In April 2023, Pace Analytical Services, a division of Pace® Science and Technology, providing local testing and analytical services announced the acquisition of Alpha Analytical, expanding its laboratory services across the Northeastern U.S. with over 39 locations
• In November 2021, Labcorp, global life sciences company inaugurated a new bioanalytical laboratory facility in Singapore, extending its central laboratory services and enhancing Singapore's biomedical ecosystem capabilities
• In November 2021, CURE Pharmaceutical Holding Corporation, pharmaceutical company obtained patent approval from the United States Patent and Trademark Office (USPTO) for its CUREfilm Blue Technology, an oral soluble film containing sildenafil citrate
• In June 2021, Charles River lab, a pharmaceutical company acquired Vigene Biosciences, a CDMO (contract development and manufacturing organization) providing viral vector-based gene delivery solutions, to strengthen its ability to support the clients with end-to-end cell and gene therapy support
• In October 2021, Syneos , biopharmaceutical solutions organization announced acquisition of RxDataScience, leading healthcare-focused data analytics, data management, and artificial intelligence (AI) company.